DNA (NYSE: DNA) Rule 144 shows insider resale notices totaling tens of thousands of shares
Rhea-AI Filing Summary
DNA submitted a Rule 144 notice reporting proposed resales of Class A common stock. The notice lists sale entries by Austin Che on 02/04/2026 (2,200 shares), 03/11/2026 (2,200 shares) and 04/13/2026 (40,893 shares) with proceeds of $262,291.79 shown for the 04/13/2026 entry. The filing also records a restricted stock vesting date of 10/20/2022 and names Fidelity Brokerage Services LLC as a broker on the notice.
Positive
- None.
Negative
- None.
Insights
Routine Rule 144 resale notice listing multiple small-to-moderate seller filings.
The filing is procedural: it lists specific resale entries by an individual seller and a broker. The amounts cited (2,200; 2,200; 40,893 shares) and a proceeds figure ($262,291.79) are explicit in the excerpt and indicate reported resale activity rather than an issuer capital raise.
Key dependencies are transferability conditions tied to the restricted stock vesting date (10/20/2022) and broker routing via Fidelity Brokerage Services LLC. Subsequent SEC filings or trade reports would confirm settlement and any market impact.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Vesting financial
Issuer financial
AI-generated analysis. How Rhea-AI works. Not financial advice.